Drug Utilization Review

Drug Utilization Review (DUR) promotes appropriate use of pharmaceuticals in the outpatient Medicaid program through education of practitioners.

Meetings

The DUR Board meeting schedule for 2012 is:

• January 26, 2012 - Agenda
• April 12, 2012
• August 16, 2012
• November 15, 2012

DUR Board

The Texas DUR Board is composed of physicians and pharmacists that meet quarterly to determine criteria for retrospective and prospective DUR. The current members are:

• Anthony J. Busti, Pharm.D, (Chairman)
  Dallas, TX
  
• Robert L. Hogue, M.D. (Vice-Chair)
  Brownwood, TX
  
• VirGene K. Adams R.PH
  Frisco, TX
  
• Laura E. Ferguson, MD
  Houston, TX
  
• Mark S. Gittings, D.O.
  Lubbock, TX
  
• Rolf W. Habersang, M.D.
  Amarillo, TX
  
• Leroy C. Knodel, Pharm.D.
  San Antonio, TX
  
• Valerie W. Robinson, M.D.
  Lubbock, TX
  
• Carlos X. Solis, R.Ph.
  McAllen, TX
  
• Jeanne D. Waggener, R.Ph.
  Bellmead, TX

• Texas Vendor Drug Program Formulary Information
• OBRA '90 Overview relating to Medicaid Drug Use Review
• Texas State Board of Pharmacy Prospective DUR/Patient Counseling Rules
• Drug Use Compendia

Other information:

• Pharmaceutical and Therapeutics Committee